Publications

Our succes in integrating information into models that generate unique insights, allowing executives to make better drug development decisions, is reflected in our gold-standard research publications.

Latest publications

Pharmacokinetics and Safety Evaluation of Maribavir in Healthy Japanese and Matched White Participants: A Phase I, Open-Label Study | Infectious diseases

Song I et al. | qP contributors: Suttle B | 2023| Journal| Clinical Pharmacology in Drug Development Link

Barriers to global pharmacometrics: educational challenges and opportunities across the globe | All

Michelet R et al. | qP contributors: Michelet R | 2023| Journal| CPT: Pharmacometrics & Systems Pharmacology Link

Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib Plus Osimertinib in an EGFR-Mutation Positive, MET-Amplified Non-Small Cell Lung Cancer Model | Oncology

Jones RDO et al. | qP contributors: Petersson, K | 2023| Journal| Molecular Cancer Therapeutics Link

Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients | Infectious diseases

Carrothers TJ et al. | qP contributors: Lagraauw HM; Lindbom L | 2023| Journal| Pediatric Infectious Disease Journal Link

Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans | Infectious diseases

Schulz J et al. | qP contributors: Michelet R | 2022| Journal| Pharmaceutical Research Link

Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion | Infectious diseases

Nassar YM et al. | qP contributors: Michelet R | 2022| Journal| Clinical Pharmacokinetics Link

The Impact of Low Cardiac Output on Propofol Pharmacokinetics across Age Groups-An Investigation Using Physiologically Based Pharmacokinetic Modelling | Cardiovascular diseases

Allegaert K et al. | qP contributors: Michelet R | 2022| Journal| Pharmaceutics Link

Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development | Analgesia

van Niel J et al. | qP contributors: | 2022| Journal| International Journal of Molecular Sciences Link

Model-informed drug development of voxelotor in sickle cell disease: Population pharmacokinetics in whole blood and plasma | Haematology

Savic RM et al. | qP contributors: Green M | 2022| Journal| CPT: Pharmacometrics & Systems Pharmacology Link

Allopregnanolone Concentrations in Breast Milk and Plasma from Healthy Volunteers Receiving Brexanolone Injection, With Population Pharmacokinetic Modeling of Potential Relative Infant Dose | CNS

Wald J et al. | qP contributors: Henningsson A; Hanze E | 2022| Journal| Clinical Pharmacokinetics Link
Get in touch
Mail
Phone (US)
+1 919 324 5670
Phone (EU)
+46 70722 90 35
Connect with us